Molecular Imaging

Serac highlights study on 99mTc-maraciclatide for endometriosis care

By AuntMinnie.com staff writers

Serac Healthcare is highlighting success from a study that evaluated the company's gamma-emitting radiotracer, 99mTc-maraciclatide.

April 30, 2026

Endometriosis 3 D Illustration 400

Lu-177 PSMA-SPECT/CT predicts survival in mCRPC

Lu-177 PSMA-617 SPECT/CT total tumor volume complete response at six weeks associated with overall survival.

April 29, 2026

Quantification of total tumor volume (TTV) at lutetium-177 prostate-specific membrane antigen (PSMA)–617 SPECT/CT shows heterogeneous TTV responses between dose 1 (Cycle #1) and dose 2 (Cycle #2) in participants with metastatic castration-resistant prostate cancer. Posttherapy coronal attenuation-corrected noncontrast SPECT/CT maximum intensity projection images demonstrate (A) near-complete response in a 76-year-old man, (B) complete response in an 83-year-old man, (C) partial TTV reduction (not complete response) in a 69-year-old man, and (D) TTV increase (i.e. progressive disease) in a 74-year-old man. Blue-shaded regions represent semiautomatically segmented PSMA-avid tumor volume, with associated TTV values given at the bottom of each panel. The gradient bar shows standardized uptake value (SUV) from 0 to 5.

ChatGPT matches nuclear medicine experts on FDG-PET/CT scans

Models excelled on cases with well-defined metabolic patterns, such as in typical cases of Alzheimer's disease, yet were less accurate on complex cases.

April 24, 2026

TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies

By AuntMinnie.com staff writers

TAG1 and NRG Pallas aim to develop access to lead-212 (Pb-212) for cancer drug development across Europe.

April 22, 2026

A Rk Nx1 Fop15 Je H Jffj8rq D13

PET links brain metabolism to survival in lung cancer patients

Low brain metabolic activity was associated with increased mortality in patients with advanced NSCLC.

April 9, 2026

A visual abstract of the study

Lu-177 supply chain gets boost with NRG Pallas, Morpho partnership

By AuntMinnieEurope.com staff writers

Firms target early 2027 for Initial commercial delivery.

April 3, 2026

Atom Nuclear Lab Thumb

New recommendations issued on tau PET imaging

By AuntMinnie.com staff writers

Standardized imaging procedures are essential to facilitate the integration of tau PET into clinical workflows.

March 31, 2026

Examples of tau PET patterns in atypical AD and 4R tauopathies. Three axial slices upon MRI or MRI template show radiotracer distribution in exemplary cases of atypical AD and progressive supranuclear palsy (PSP).

Astral Systems, Brazil's IPEN sign isotope production partnership

By AuntMinnieEurope.com staff writers

The partnership will initially focus on using Astral’s multistate fusion neutron generation technology to establish a new supply stream for actinium-225.

March 25, 2026

Nuclear Medicine Worker Sm

New FAPI tracer shows promise across 19 solid tumor types

PET using fibroblast activation protein inhibitor (FAPI) tracers has emerged as a robust imaging tool for detecting solid tumors.

March 23, 2026

2026 03 23 Fapi Pet Thumbnail

Clarity highlights Cu-64 PSMA-PET/CT study results

By AuntMinnieEurope.com staff writers

The study compares Clarity's copper-64 (Cu-64) SAR-bisPSMA PET/CT agent with standard gallium-68 PSMA-11 PET/CT.

March 18, 2026

DeepHealth TechLive remote imaging solution wins CE Mark

By AuntMinnieEurope.com staff writers

DeepHealth has secured a CE Mark for its TechLive remote imaging and radiology management solution, enabling commercialization in Europe.

February 27, 2026

Global groups seek to expand access to theranostics

By AuntMinnieEurope.com staff writers

The International Centers for Precision Oncology Foundation and the World Federation of Nuclear Medicine and Biology are collaborating to expand access to theranostics.

February 27, 2026

Global Connections

Page 1 of 126